Karyopharm was founded in 2009 by scientists linked to organizations such as Copenhagen University Hospital, Boston???s Dana-Farber Cancer Institute, Harvard Medical School, and Epix Pharmaceuticals, a Lexington, MA-based drug developer that shut down in 2009.